Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy ExtensionActive Not Recruiting
NCT02843035Phase 2Updated Jul 10, 2026
Sponsor: Genzyme, a Sanofi Company
Gaucher Disease Type 1 · Gaucher Disease Type 3
United States, Germany, Japan, United Kingdom
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid TumorsActive Not Recruiting
NCT05101096Phase 1, Phase 2Updated Jul 10, 2026
Sponsor: Gilead Sciences
Advanced Solid Tumor · Metastatic Triple-Negative Breast Cancer · HR+/HER2- Metastatic Breast Cancer · Metastatic Urothelial Cancer
Japan
A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 MutationsActive Not Recruiting
NCT05048797Phase 3Updated Jul 10, 2026
Sponsor: AstraZeneca
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
United States, Austria, Belgium, Brazil, Canada +15 more
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic DermatitisActive Not Recruiting
NCT06407934Phase 3Updated Jul 10, 2026
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Australia, Brazil, Bulgaria +22 more
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of DiseaseRecruiting
NCT07023289Phase 2Updated Jul 10, 2026
Sponsor: AbbVie
Colorectal Cancer
United States, Belgium, Denmark, Italy, Japan +3 more
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-GuerinActive Not Recruiting
NCT04452591Phase 3Updated Jul 10, 2026
Sponsor: CG Oncology, Inc.
Non Muscle Invasive Bladder Cancer · High-grade Ta/ T1 Papillary Disease Bladder Cancer
United States, Australia, Canada, Japan, South Korea +1 more
A Study of Intrathecal SHP611 in Children With Metachromatic LeukodystrophyCompleted
NCT03771898Phase 2Updated Jul 10, 2026
Sponsor: Shire
Metachromatic Leukodystrophy (MLD)
United States, Argentina, Belgium, Brazil, Canada +9 more
A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 DiabetesCompleted
NCT06263348Phase 4Updated Jul 10, 2026
Sponsor: Hua Medicine Limited
Type2diabetes
China
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)Active Not Recruiting
NCT03148418Phase 3Updated Jul 10, 2026
Sponsor: Hoffmann-La Roche
Cancer
United States, Argentina, Australia, Austria, Belgium +27 more
An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan ProcedureActive Not Recruiting
NCT06193863N/AUpdated Jul 10, 2026
Sponsor: Bayer
Prevention of Venous Thromboembolism · Congenital Heart Disease · Fontan Procedure · Children
Japan
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute LeukemiaRecruiting
NCT05327894Phase 3Updated Jul 10, 2026
Sponsor: Princess Maxima Center for Pediatric Oncology
Acute Lymphoblastic Leukemia · Mixed Phenotype Acute Leukemia
Argentina, Australia, Austria, Belgium, Czechia +19 more
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)Active Not Recruiting
NCT06109779Phase 3Updated Jul 10, 2026
Sponsor: AstraZeneca
Biliary Tract Cancer
United States, Australia, Belgium, Brazil, Canada +16 more
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)Recruiting
NCT04379596Phase 2Updated Jul 10, 2026
Sponsor: AstraZeneca
Gastric Cancer
United States, Brazil, Canada, China, Germany +9 more
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued TreatmentNot Yet Recruiting
NCT07691970Phase 3Updated Jul 9, 2026
Sponsor: AstraZeneca
Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus
United States, Austria, Belgium, Brazil, Bulgaria +17 more
An Extension Study for Treatment of Moderately to Severely Active Ulcerative ColitisActive Not Recruiting
NCT03950232Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Ulcerative Colitis
United States, Argentina, Australia, Austria, Belarus +34 more
Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular LymphomaCompleted
NCT03568461Phase 2Updated Jul 9, 2026
Sponsor: Novartis Pharmaceuticals
Follicular Lymphoma
United States, Australia, Austria, Belgium, France +7 more
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are ToleratedActive Not Recruiting
NCT05327946Phase 1Updated Jul 9, 2026
Sponsor: Boehringer Ingelheim
Solid Tumors
United States, Canada, Japan
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.Recruiting
NCT07629440Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Pneumococcal Disease
United States, Japan, Puerto Rico
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual MigraineRecruiting
NCT06641466Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Menstrual Migraine
United States, Argentina, Canada, China, Denmark +10 more
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid TumorsRecruiting
NCT07015697Phase 1Updated Jul 9, 2026
Sponsor: Daiichi Sankyo
Recurrent or Metastatic Solid Tumors
United States, Brazil, France, Japan, South Korea +2 more
A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial AneurysmsCompleted
NCT03642639NAUpdated Jul 9, 2026
Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Aneurysms
United States, Belgium, France, Germany, Israel +5 more
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for TransplantRecruiting
NCT05623020Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Multiple Myeloma
United States, Australia, Austria, Belgium, Brazil +19 more
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical TrialsActive Not Recruiting
NCT05335876Phase 3Updated Jul 9, 2026
Sponsor: Novartis Pharmaceuticals
Spinal Muscular Atrophy (SMA)
United States, Australia, Belgium, Brazil, Canada +14 more
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid TumorsTerminated
NCT03114319Phase 1Updated Jul 9, 2026
Sponsor: Novartis Pharmaceuticals
Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC) · KRAS G12-mutant NSCLC · Esophageal Squamous Cell Cancer (SCC) · Head/Neck SCC
United States, Canada, Italy, Japan, Netherlands +4 more
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2Active Not Recruiting
NCT06346392Phase 3Updated Jul 9, 2026
Sponsor: AstraZeneca
Gastric Cancer · Gastroesophageal Junction Cancer
United States, Brazil, Canada, China, France +14 more

Previous page Next page